Advertisement

Brain morphology and prediction of neuroleptic treatment response in schizophrenia

  • P. Falkai
  • B. Bogerts
Conference paper

Summary

Since the introduction of computed tomography into schizophrenia research, many studies were performed to correlate brain morphology with neuroleptic treatment response. CT measures like the VBR, third ventricular size, cerebral asymmetry and cortical enlargement yielded equivocal results. As temporal and frontal lobe structures are involved in the pathophysiology of schizophrenia, a CT scan study with 143 schizophrenic responders and non-responders after 4 weeks of haloperidol treatment was performed using 12 different measures focussing on frontal and peritemporal cerebrospinal fluid spaces. Beside a significantly enlarged basotemporal, a trendwise enlarged parasagittal cerebrospinal fluid space, and a significantly reduced frontal lobe asymmetry in non-responders, none of the other measures helped to predict short-term neuroleptic response. Methodological problems of this study and future perspectives of brain morphology in treatment prediction research are discussed.

Keywords

Schizophrenic Patient Occipital Lobe Chronic Schizophrenia Brain Morphology Temporal Horn 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bogerts B, Wurthmann C, Piroth HD (1987) Hirnsubstanzdefizit mit paralimbischem und limbischem Schwerpunkt im CT Schizophrener. Nervenarzt 58: 97–106.PubMedGoogle Scholar
  2. Boronow J, Pickar D, Ninan PT, Roy A, Hommer D, Linnoila M, Paul SM (1985) Atrophy limited to the third ventricle in chronic schizophrenic patients: report of a controlled series. Arch Gen Psychiatry 42: 266–270.PubMedCrossRefGoogle Scholar
  3. Buckmann TD, Kling A, Sutphin MS, Steinberg A, Eiduson S (1990) Platelet gluthatione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables. Psychiatry Res 31: 1–14.CrossRefGoogle Scholar
  4. Cazzullo CL (1963) Biological and clinical studies on schizophrenia related to pharmacological treatment. Rec Adv Biol Psychiatr 5: 114–143.Google Scholar
  5. DeQuardo JR, Klon R, Tandon R, Aravapalli SR (1989) Ventricular enlargement in schizophrenia: relationships to clinical parameters and DST. Biol Psychiatry 25: 97a.CrossRefGoogle Scholar
  6. Falkai P, Bogerts B, Schneider Th, Greve B, Klieser E (1993) Gestörte zerebrale Lateralität im CT Schizophrener — Eine morphometrische Studie. In: Baumann P (Hrsg) Biologische Psychiatrie der Gegenwart. Springer, Wien New York, S 517–520.Google Scholar
  7. Friedman L, Lys Ch, Schulz SC (1992) The relationship of structural brain imaging parameters to antipsychotic treatment response: a review. J Psychiatr Neurosci 17(2): 42–54.Google Scholar
  8. Gattaz WF, Rost W, Kohlmeyer K, Bauer K, Hübner C, Gasser T (1988) CT scans and neuroleptic response in schizophrenia: a multidimensional approach. Psychiatry Res 26(3): 293–303.PubMedCrossRefGoogle Scholar
  9. Jeste DV, Kleinman JE, Potkin SG, Luchins DJ, Weinberger DR (1982) Ex uno multi: subtyping the schizophrenic syndrome. Biol Psychiatry 17: 199–222.PubMedGoogle Scholar
  10. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L (1976) Cerebral ventricular size and cognitive chronic schizophrenia. Lancet ii: 924–926.CrossRefGoogle Scholar
  11. Kaiya H, Uematsu M, Ofuji, Mishida A, Morikiyo M, Adachi S (1989) Computerized tomography in schizophrenia: familial versus nonfamilial forms of illness. Br J Psychiatry 155: 444–450.PubMedCrossRefGoogle Scholar
  12. Kaplan MJ, Lazoff M, Kelly K, Lukin R, Garver DL (1990) Enlargement of the cerebral third ventricle in psychotic patients with delayed response of neuroleptics. Biol Psychiatry 27: 205–214.PubMedCrossRefGoogle Scholar
  13. Kling AS, Kurtz N, Tachiki K, Orzeck A (1983) CT scans in subgroups of chronic schizophrenics. J Psychiatry Res 17(4): 375–384.CrossRefGoogle Scholar
  14. LeMay M, Kido DK (1978) Asymmetries of the cerebral hemispheres on computed tomograms. J Comput Assist Tomogr 2: 471–476.CrossRefGoogle Scholar
  15. Losonczy MF, Song IS, Mohs RC, Small NA, Davidson M, Johns CA, Davis KL (1986) Correlates of lateral ventricular size in chronic schizophrenia. I. Behavioral and treatment response measures. Am J Psychiatry 143(8): 976–981.PubMedGoogle Scholar
  16. Luchins DJ, Weinberger DR, Wyatt RJ (1979) Schizophrenia: evidence of a subgroup with reversed cerebral asymmetry. Arch Gen Psychiatry 36: 1309–1311.PubMedCrossRefGoogle Scholar
  17. Luchins DJ, Weinberger DR, Wyatt RJ (1982) Schizophrenia and cerebral asymmetry detected by computed tomography. Am J Psychiatry 139: 753–757.PubMedGoogle Scholar
  18. Luchins DJ, Lewine RRJ, Melzer MY (1983) Lateral ventricular size in the psychoses: relation to psychopathology and therapeutic and adverse response to medications. Psycho-pharmacol Bull 19: 518–522.Google Scholar
  19. Luchins DJ, Meltzer HJ (1983) A blind controlled study of occipital cerebral asymmetry in schizophrenia. Psychiatry Res 10: 87–95.PubMedCrossRefGoogle Scholar
  20. Luchins DJ, Meltzer HJ (1986) A comparison of CT findings in acute and chronic ward schizophrenics. Psychiatry Res 17: 7–14.PubMedCrossRefGoogle Scholar
  21. MacDonald HL, Best JJK (1989) The Scottish first episode schizophrenia study. IV. Computerized tomographic brain scans in patients and controls. Br J Psychiatry 154: 492–498.PubMedCrossRefGoogle Scholar
  22. Naber D, Albus M, Burke H, Spahn F, Munch U, Reinertshofer T, Wissmann J, Ackenheil M (1985) Neuroleptic withdrawl in chronic schizophrenia: CT and endocrine variables relating to psychopathology. Psychiatry Res 16: 207–219.PubMedCrossRefGoogle Scholar
  23. Nasrallah HA, Kleinman JL, Weinberger DR, Gillin JC, Wyatt RJ (1980) Cerebral ventricular enlargement and dopamine synthesis inhibition in chronic schizophrenia. Arch Gen Psychiatry 37: 1427.PubMedCrossRefGoogle Scholar
  24. Nasrallah HA, Kuperman S, Hamra BJ, McCalley-Whitters M (1983a) Clinical differences between schizophrenic patients with and without large cerebral ventricles. J Clin Psychiatry 44 (11): 407–409.PubMedGoogle Scholar
  25. Nasrallah HA, Kuperman S, Jacoby CG, McCalley-Whitters M, Hamra B (1983b) Clinical correlates of sulcal widening in chronic schizophrenia. Psychiatry Res 10: 237–242.PubMedCrossRefGoogle Scholar
  26. Nimgaonkar VL, Wessely S, Tune LE, Murray RM (1988) Response to drugs in schizophrenia: the influence of family history, obstetric complications and ventricular enlargement. Psychol Med 18:583–592.PubMedCrossRefGoogle Scholar
  27. Nian PT, Yadlam K, Jacobs M, Lieberman JA, Sweeney J, Severe J (1989) CT Morphology and short term outcome in schizophrenia. Schizophr Res 2: 137.CrossRefGoogle Scholar
  28. Pandurangi AK, Devan MJ, Boucher M, Levy BF, Ramachandran T, Bartell K, Bick PA, Phelps BH, Major L (1986) A comprehensive study of schizophrenic patients. II. Biological, neuropsychological and clinical correlates of CT abnormality. Acta Psychiatr Scand 73: 161–171.PubMedCrossRefGoogle Scholar
  29. Pandurangi AK, Goldberg SC, Brink DD, Hill MH, Gulati AN, Hamer RM (1989) Amphetamine challange test, response to treatment, and lateral ventricle size in schizophrenia. Biol Psychiatry 25: 207–214.PubMedCrossRefGoogle Scholar
  30. Schulz SC, Sinicrope P, Kishore PR, Freidel RO (1983) Treatment response and ventricular brain enlargement in young schizophrenic patients. Psychopharmacol Bull 19: 510–512.PubMedGoogle Scholar
  31. Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR (1988) Cerebral structural pathology in schizophrenia: Evidence for a selective prefrontal cortical defect. Am J Psychiatry 145: 154–163.PubMedGoogle Scholar
  32. Silverman JM, Mohs RC, Davidson M, Losoncy MF, Keefe RS, Breitner JC, Sorokin JE, Davis KL (1987) Familial schizophrenia and treatment response. Am J Psychiatry 144(10): 1271–1276.PubMedGoogle Scholar
  33. Smith RC, Maser J (1983) Morphological and neuropsychological abnormalities as predictors of clinical response to psychotropic drugs. Psychopharmacol Bull 19: 505–509.PubMedGoogle Scholar
  34. Smith RC, Baumgartner R, Ravichandron GK, Mauldin M, Burd A, Vroulis G, Gordon J, Calderon M (1985) Lateral ventricular enlargement and clinical response in schizophrenia. Psychiatry Res 14: 241–253.PubMedCrossRefGoogle Scholar
  35. Smith RC, Baumgartner R, Ravichandran GK, Largen J, Calderon M, Burd A, Mauldin M (1987) Cortical atrophy and white matter density in the brains of schizophrenics. Acta Psychiatr Scand 75: 11–19.PubMedCrossRefGoogle Scholar
  36. Tsai LY, Nasrallah HA, Jacoby CG (1983) Hemispheric asymmetries on computed tomographic scans in schizophrenia and mania: a controlled study and critical review. Arch Gen Psychiatry 40: 1286–1289.PubMedCrossRefGoogle Scholar
  37. Weinberger DR, Bigelow LB, Kleinman JE (1980) Cerebral ventricular enlargement in chronic schizophrenia: its association with poor response to treatment. Arch Gen Psychiatry 37: 11–13.PubMedCrossRefGoogle Scholar
  38. Weinberger DR, DeLisi LE, Perman GP, Targum S, Wyatt RJ (1982) Computed tomography in schizophreniform disorder and other acute psychiatric disorders. Arch Gen Psychiatry 39: 778–783.PubMedCrossRefGoogle Scholar
  39. Zatz LM, Jernigan TL, Ahumada AJ (1982) Changes in computed cranial tomography with aging: intracranial fluid volume. Am J Neuroradiol 3: 1–11.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 1994

Authors and Affiliations

  • P. Falkai
    • 1
  • B. Bogerts
    • 2
  1. 1.Department of PsychiatryUniversity of DüsseldorfDüsseldorfGermany
  2. 2.Department of PsychiatryUniversity of MagdeburgGermany

Personalised recommendations